Biotechnology | Financial Buzz

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

FDA Grants Fast Track Destination for ERYASPASE to Treat Acute Lymphocytic Leukemia

Bryan Shin07/30/2021

2579

ERYTECH Pharma (NASDAQ: ERYP) has reported that the U.S. Food and Drug Administration has granted eryaspase Fast Track designation for treatment of acute lymphocytic leukemia in patients who have...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Phase 2/3 Clinical Trials for Tollovir

financial buzz07/28/202107/28/2021

2013

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Retains CRO for COVID-19 Outpatient and Inpatient Phase 2/3 Clinical Trials for Oral Antiviral...

Biotechnology Breaking News Healthcare Investing News Market News Technology

Breaking News: Todos Medical Retains CRO for COVID-19 Outpatient and Inpatient Phase 2/3 Clinical Trials for Oral Antiviral 3CL Protease Inhibitor Tollovir

financial buzz07/28/202107/28/2021

5197

Trials will separately enroll non-hospitalized and hospitalized patients Clinical trials in India targeted to be adaptive design to enable expansion into pivotal development upon achieving data milestone Todos Medical,...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Receives FDA Certificate for Tollovid Daily

financial buzz07/22/2021

2095

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Receives New FDA Certificate of Free Sale for Tollovid Daily™ Including 3CL Protease Inhibitor...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Todos Medical Receives New FDA Certificate of Free Sale for Tollovid Daily™ Including 3CL Protease Inhibitor Claim

financial buzz07/22/2021

4500

New twice-a-day dosing regimen allows for daily immune system support Company intends to create a monthly subscription model for this new product Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive...

Biotechnology Breaking News Healthcare Investing News Market News Special Guest Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Lexaria Bioscience Corp. (NASDAQ: LEXX) Rises 26% on Positive Study Results

financial buzz07/21/202107/21/2021

2021

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Lexaria Bioscience Corp. Skyrocketed 26% Following Positive Study Results” Lexaria Bioscience Corp. (NASDAQ: LEXX) surged over 26% in...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Lantern Pharma (NASDAQ: LTRN) Positive Cancer Collaboration Data

financial buzz07/20/2021

1783

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Lantern Pharma Surged 10% Following Positive Cancer Collaboration Data” Lantern Pharma (NASDAQ: LTRN) climbed over 10% in early...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) to Launch Antibody Kit with Fosun Pharma

financial buzz07/19/2021

1572

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical to Launch EUA Authorized cPass SARS-CoV-2 Neutralizing Antibody Kit Through Agreement with Fosun Pharma.”...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Todos Medical to Launch EUA Authorized cPass SARS-CoV-2 Neutralizing Antibody Kit Through Agreement with Fosun Pharma

financial buzz07/19/202107/19/2021

4987

Nature Medicine publication shows that neutralizing antibodies are critical to prevent or reduce the severity of a COVID-19 infection, including infection by emerging COVID-19 variants such as the Delta...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Appoints Halperin as Corporate Controller

financial buzz07/09/2021

1818

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Appoints Ilanit Halperin, CPA as Corporate Controller.” Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive...

Tag: Biotechnology

FDA Grants Fast Track Destination for ERYASPASE to Treat Acute Lymphocytic Leukemia

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Phase 2/3 Clinical Trials for Tollovir

Breaking News: Todos Medical Retains CRO for COVID-19 Outpatient and Inpatient Phase 2/3 Clinical Trials for Oral Antiviral 3CL Protease Inhibitor Tollovir

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Receives FDA Certificate for Tollovid Daily

Breaking News: Todos Medical Receives New FDA Certificate of Free Sale for Tollovid Daily™ Including 3CL Protease Inhibitor Claim

“The Buzz” Show: Lexaria Bioscience Corp. (NASDAQ: LEXX) Rises 26% on Positive Study Results

“The Buzz” Show: Lantern Pharma (NASDAQ: LTRN) Positive Cancer Collaboration Data

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) to Launch Antibody Kit with Fosun Pharma

Breaking News: Todos Medical to Launch EUA Authorized cPass SARS-CoV-2 Neutralizing Antibody Kit Through Agreement with Fosun Pharma

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Appoints Halperin as Corporate Controller

ABOUT US

Tweets